Compare CIEN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIEN | LNTH |
|---|---|---|
| Founded | 1992 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.7B | 6.7B |
| IPO Year | 1996 | 2014 |
| Metric | CIEN | LNTH |
|---|---|---|
| Price | $379.99 | $100.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $382.69 | $87.00 |
| AVG Volume (30 Days) | 1.9M | ★ 2.0M |
| Earning Date | 06-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.55 | N/A |
| EPS | 2.52 | ★ 2.91 |
| Revenue | ★ $4,769,507,000.00 | $343,374,000.00 |
| Revenue This Year | $30.83 | N/A |
| Revenue Next Year | $19.87 | $14.19 |
| P/E Ratio | $158.67 | ★ $34.53 |
| Revenue Growth | ★ 18.79 | 3.62 |
| 52 Week Low | $90.00 | $49.67 |
| 52 Week High | $637.51 | $111.86 |
| Indicator | CIEN | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 44.91 |
| Support Level | $368.30 | $99.80 |
| Resistance Level | $429.90 | $102.66 |
| Average True Range (ATR) | 22.71 | 0.49 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 31.25 | 38.24 |
Ciena is a leader in high-speed optical connectivity, providing systems, components, and automation software for telecom providers and enterprises, such as data centers, to enable long-distance connectivity. The company operates through four primary business segments: networking platforms, platform software and services, Blue Planet automation software, and global services. While telecom carriers remain important customers, cloud providers and hyperscalers now drive a significant portion of the business. To meet the demands of AI data centers, customers are adopting Ciena's WaveLogic 6 platform, the first to support 1.6 terabits-per-second capacity.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.